Asset Details
Do you wish to reserve the book?
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Do you wish to request the book?
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
2012
Overview
Background
Tumor associated macrophages (TAMs) are alternatively activated macrophages that enhance tumor progression by promoting tumor cell invasion, migration and angiogenesis. TAMs have an anti-inflammatory function resembling M2 macrophages. CD163 is regarded as a highly specific monocyte/macrophage marker for M2 macrophages. In this study we evaluated the specificity of using the M2 macrophage marker CD163 as a TAM marker and compared its prognostic value with the more frequently used pan-macrophage marker CD68. We also analyzed the prognostic value of the localization of CD163
+
and CD68
+
myeloid cells in human breast cancer.
Methods
The extent of infiltrating CD163
+
or CD68
+
myeloid cells in tumor nest versus tumor stroma was evaluated by immunohistochemistry in tissue microarrays with tumors from 144 breast cancer cases. Spearman’s Rho and χ
2
tests were used to examine the correlations between CD163
+
or CD68
+
myeloid cells and clinicopathological parameters. Kaplan Meier analysis and Cox proportional hazards modeling were used to assess the impact of CD163
+
and CD68
+
myeloid cells in tumor stroma and tumor nest, respectively, on recurrence free survival, breast cancer specific and overall survival.
Results
We found that infiltration of CD163
+
and CD68
+
macrophages into tumor stroma, but not into tumor nest, were of clinical relevance. CD163
+
macrophages in tumor stroma positively correlated with higher grade, larger tumor size, Ki67 positivity, estrogen receptor negativity, progesterone receptor negativity, triple-negative/basal-like breast cancer and inversely correlated with luminal A breast cancer. Some CD163
+
areas lacked CD68 expression, suggesting that CD163 could be used as a general anti-inflammatory myeloid marker with prognostic impact. CD68
+
macrophages in tumor stroma positively correlated to tumor size and inversely correlated to luminal A breast cancer. More importantly, CD68 in tumor stroma was an independent prognostic factor for reduced breast cancer specific survival.
Conclusion
These findings highlight the importance of analyzing the localization rather than merely the presence of TAMs as a prognostic marker for breast cancer patients.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Aged
/ Analysis
/ Antigens, Differentiation, Myelomonocytic - metabolism
/ Biomedical and Life Sciences
/ Breast Neoplasms - metabolism
/ Breast Neoplasms - mortality
/ Breast Neoplasms - pathology
/ CD163
/ CD68
/ Estrogen
/ Female
/ Health Promotion and Disease Prevention
/ Humans
/ Oncology
/ Receptors, Cell Surface - metabolism
/ Tumor associated macrophages
/ Tumors
